JW PHARMACEUTICAL CORPORATION

Other languages JW Pharmaceutical Corporation

Equities

A001060

KR7001060003

End-of-day quote Korea S.E. Other stock markets 23:00:00 13/05/2024 BST			5-day change	1st Jan Change
30,400 ^KRW	+1.00%		+0.16%	-14.49%

03-14	JW Pharmaceutical Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	CI
01-22	CJ Logistics Secures Distribution Deal for JW Pharm's Intravenous Solutions	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

JW Pharmaceutical Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	03-14
CJ Logistics Secures Distribution Deal for JW Pharm's Intravenous Solutions	01-22
JW Pharmaceutical Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-14
South Korean Shares Touch Seven-Month Low on Concerns over US Fed Rate Hikes	20/10/23
JW Pharmaceutical Faces Potential Fine of Nearly 30 Billion Won for Alleged Illegal Rebates	20/10/23
El Kospi de Corea cae un 0,6%, su mayor racha de pérdidas desde junio de 2022 -- Market Talk	18/08/23
JW Pharmaceutical Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14/08/23
JW Pharmaceutical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	15/05/23
Celleron Therapeutics Ltd acquired Argonaut Therapeutics Limited from JW Pharmaceutical Corporation and Oxford Science Enterprises.	04/01/23
JW Pharmaceutical Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	15/11/22
JW Pharmaceutical to Raise $3 Million via Share Sale	20/10/22
JW Pharmaceutical Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	16/08/22
JW Pharmaceutical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022	16/05/22
JW Pharmaceutical Corporation Reports Earnings Results for the Full Year Ended December 31, 2021	21/03/22
JW Pharmaceutical Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	15/11/21
Market Chatter: JW Pharmaceutical Gets German Health Body's Permit for Phase 2a Study of Oral Atopic Dermatitis Drug	21/04/21

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+39.41% on our US portfolio vs. 25.67% on the S&P 500 net Total Return

Replicate our performance

fermer